STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patentSTAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Novo Nordisk has filed a lawsuit accusing Hims & Hers of infringing on a key patent for its widely sold Wegovy weight loss treatment, a new legal tactic by the drugmaker as it tries to thwart compounded versions of its big-selling medicine. Specifically, Novo Nordisk claims the telehealth platform infringed on the patent for semaglutide, Read More
How associations between historical redlining and breast cancer survival changed over timeHow associations between historical redlining and breast cancer survival changed over time
A 1930s to 1960s residential segregation policy has been linked to shorter survival time in people with breast cancer. New research reveals that this association has changed over time, with disparities narrowing until recently. The findings are published in Cancer.
You’ve reached your weight loss goal on GLP-1 medications. What now?You’ve reached your weight loss goal on GLP-1 medications. What now?
GLP-1 drugs have ushered in a new era in weight loss. GLP-1 drugs have ushered in a new era in weight loss.
Teddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fightTeddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fight
“Real Housewives” star and “The Masked Singer” contestant Teddi Mellencamp opens up about her stage four melanoma recovery and why she won’t leave LA despite her famous father’s wishes.
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of WegovySTAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
The Department of Health and Human Services asked the Department of Justice to investigate Hims & Hers for potentially violating federal law over its plan to make a compounded version of a low-cost weight loss pill widely available on its telehealth platform, according to a social media post by HHS general counsel Mike Stuart. The Read More
3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma
(MedPage Today) — Bioengineered tissue produced with a 3D printer could offer a reconstruction solution that “allows a woman to be whole again” after breast cancer surgery. (CNN)
Aging in fast forward: A husband-caregiver documents his wife’s…
Synergizing global clinical trials data: GLP-1 receptor agonist safety and novel clinical applicationsSynergizing global clinical trials data: GLP-1 receptor agonist safety and novel clinical applications
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide clinical trial data through a series of meta-analyses on GLP‑1 receptor agonists, an emerging cardiometabolic drug, offering in-depth insights into its safety profile Read More
New tool spots early signs of infection after breast cancer reconstructionNew tool spots early signs of infection after breast cancer reconstruction
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many of those women opt to have their breasts surgically reconstructed, most commonly with implants, but a relatively high percentage develop infections after implant surgery, requiring intravenous antibiotics and often removal of the implant. This can lead to additional surgeries, delays in cancer care and increased costs, as well as added emotional distress for women already under strain from cancer diagnosis and treatment.
‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasize’Sticky coat’ boosts triple negative breast cancer’s ability to metastasize
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs. Metastasis is the leading cause of cancer-related deaths and scientists are investigating ways to prevent it.
Use of GLP-1 Drugs Under Scrutiny at Winter OlympicsUse of GLP-1 Drugs Under Scrutiny at Winter Olympics
(MedPage Today) — As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an unexpected class of drugs: GLP-1 receptor agonists. An advisory group that makes recommendations about WADA’s list of prohibited… (MedPage Today) — As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an Read More